NLS Pharmaceutics (NLSPW) had the highest return on October 2, 2023 by a US stock, returning 81.8%.

ASSET	DATE	% RETURN
NLS Pharmaceutics (NLSPW)	10/2/2023	81.82%
AEye (LIDRW)	10/2/2023	80.18%
GeneDx (WGSWW)	10/2/2023	43.89%
Jasper Therapeutics (JSPRW)	10/2/2023	41.48%
Oncology Institute (TOIIW)	10/2/2023	37.2%
Swvl Holdings Corp Warrant (SWVLW)	10/2/2023	37.14%
error (ZVZZT)	10/2/2023	35.33%
Celularity (CELUW)	10/2/2023	35.14%
Palladyne AI (PDYNW)	10/2/2023	34.5%
Universe Pharmaceuticals (UPC)	10/2/2023	34.38%
Pasithea Therapeutics Corp Warrant (KTTAW)	10/2/2023	29.03%
Firefly Neuroscience (AIFF)	10/2/2023	28%
SRx Health Solutions (SRXH)	10/2/2023	27.95%
LMF Acquisition Opportunities (ICU)	10/2/2023	27.52%
Neuphoria Therapeutics (NEUP)	10/2/2023	25.48%
BTC Digital (BTCT)	10/2/2023	24.28%
Connect Biopharma (CNTB)	10/2/2023	22.1%
Immix Biopharma (IMMX)	10/2/2023	21.97%
Paysafe Ltd Wt (PSFE.WT)	10/2/2023	20.75%
P3 Health Partners (PIII)	10/2/2023	20%
MAIA Biotechnology (MAIA)	10/2/2023	19.81%
Eastside Distilling (BLNE)	10/2/2023	19.71%
Intensity Therapeutics, Inc Common stock (INTS)	10/2/2023	17.46%
bioAffinity Technologies (BIAF)	10/2/2023	17.36%
NeoVolta Inc Warrant (NEOVW)	10/2/2023	17.18%